![]() |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Diseases Treatable with Stem Cells Current Applications Umbilical cord blood is rich in haematopoietic stem cells which means they have the ability to evolve into all the specific cell types in the blood and immune system. Thus, umbilical cord blood stem cells are used to treated blood and blood related diseases.
Two other sources of stem cells can also be used – the bone marrow of an adult or the peripheral blood of an adult. The treating doctor will decide which source of stem cells to use depending on several factors, including but not limited to: the degree of match between donor and patient, the expected speed of engraftment and the amount of time available to search for a matching donor.
The following table lists diseases for which haematopoietic stem cells are a standard treatment. For some diseases they are the only therapy and for others, they are employed when front-line therapies have failed or the disease is very aggressive.
Future link to more comprehensive list in Health Professionals section. Haematopoietic stem cells can be retrieved from 3 types of donors:
Autologous transplantation Autologous transplantation means that the donor and the recipient is the same person. This type of transplantation refers to the situation where the child’s own stem cells are used for themselves. It needs to be noted that autologous transplantation cannot be used in the treatment of inherited disorders. The reason being that the genes that code for the inherited disorder are carried in every cell i.e. they will also be found in the person’s stem cells. So, we cannot return cells containing genes for a disorder back into the person after we have treated them for the disorder. In that case, an allogenic donor will be used. Traditionally, autologous transplantation was not done for acute leukaemia’s in children. However, views on this subject are changing and autologous transplantations are being tried in childhood leukaemia. Allogenic transplantation This type of transplant is a transplant between two genetically non-identical individuals. These individuals may be related family members or completely unrelated. Allogenic transplants (allograft) may be used in the treatment of inherited and non- inherited disorders. Before doing an allograft, the recipient needs to find a matching donor. HLA matching necessary for transplants Prior to allogenic stem cell transplantation, HLA – type matching needs to take place. A 6/6 HLA match is necessary for bone marrow and peripheral blood stem cell transplants. Due to the “immature immunity” of umbilical cord blood only a 3-4/6 HLA match is necessary. The implications of this are:
The amount of stem cells necessary for transplantation Currently, the average number of stem cells collected from an umbilical cord blood collection will treat up to a 50kg person. The optimal dose is about 20 million nucleated cells per kilogram of body weight. As stated above, multiple, mismatched cord blood units can be used simultaneously in a transplant for an individual over 50kg in weight. The use of cord blood for adults is being enhanced by expanding the number of stem cells in vitro. Companies are developing techniques to rapidly grow stem cells in a laboratory environment and these are being used in clinical trials. Long term viability of frozen cord blood Thus far it has been proven that there is a recovery of over 90% of viable stem cells after thawing units that have been cryogenically frozen for 15 years. Future Applications The future medical potential of stem cells is what has made this subject so fascinating, yet controversial. Significant research is being undertaken worldwide in stem cell therapies including:
Who Can Use the Stem Cells? Stem cells represent a perfect match for the child whose cord blood stem cells have been stored, with no risk of rejection.
There is also an excellent possibility that the stem cells will be a suitable match for family members and/or close relatives:
Chances of Needing the Stem Cells? Hopefully they will never be needed and should be regarded as an extra form of medical insurance. The diseases that stem cells can currently treat are not common and therefore, the chances of using the cells are thankfully rare. Studies in the US have been done to calculate the lifetime probability (age 0-70) that an individual will undergo a stem cell transplant. They reported that 1:435 people will receive their own stem cells for treatment; 1:400 persons will receive someone else’s stem cells; and the combined total number of stem cell transplants will be 1:217 persons. With all the current research being undertaken, it is likely that retrievals will increase in the future, as more diseases become treatable through stem cell therapy. Reasons to Consider Storing your Baby’s Stem Cells
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||